<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>The World Health Organization reports that the prevalent problem of excessive weight and obesity currently affects about 1.9 billion people worldwide and is the fifth most common death factor among patients. In view of the growing number of patients with obesity, attention is drawn to the insufficient effectiveness of behavioral treatment methods. In addition to genetic and environmental factors leading to the consumption of excess energy in the diet and the accumulation of adipose tissue, attention is paid to the role of intestinal microbiota in maintaining a normal body weight. Dysbiosis – a disorder in the composition of the gut microbiota – is mentioned as one of the contributing factors to the development of metabolic diseases, including obesity, type 2 diabetes, and cardiovascular disorders. The human gastrointestinal tract is colonized largely by a group of Gram-negative bacteria that are indicated to be a source of lipopolysaccharide (LPS), associated with inducing systemic inflammation and endotoxemia. Research suggests that disturbances in the gut microbiota, leading to damage to the intestinal barrier and an increase in circulating LPS, are implicated in obesity and other metabolic disorders. Plasma LPS and lipopolysaccharide-binding protein (LBP) levels have been shown to be elevated in individuals with excess body weight. Bariatric surgery has become a popular treatment option, leading to stable weight loss and an improvement in obesity-related conditions. The aim of this study was to characterize the factors that promote the induction of metabolic endotoxemia and its associated health consequences, along with the presentation of their changes after bariatric surgery.</p>
</abstract>

The World Health Organization reports that the prevalent problem of excessive weight and obesity currently affects about 1.9 billion people worldwide and is the fifth most common death factor among patients. In view of the growing number of patients with obesity, attention is drawn to the insufficient effectiveness of behavioral treatment methods. In addition to genetic and environmental factors leading to the consumption of excess energy in the diet and the accumulation of adipose tissue, attention is paid to the role of intestinal microbiota in maintaining a normal body weight. Dysbiosis – a disorder in the composition of the gut microbiota – is mentioned as one of the contributing factors to the development of metabolic diseases, including obesity, type 2 diabetes, and cardiovascular disorders. The human gastrointestinal tract is colonized largely by a group of Gram-negative bacteria that are indicated to be a source of lipopolysaccharide (LPS), associated with inducing systemic inflammation and endotoxemia. Research suggests that disturbances in the gut microbiota, leading to damage to the intestinal barrier and an increase in circulating LPS, are implicated in obesity and other metabolic disorders. Plasma LPS and lipopolysaccharide-binding protein (LBP) levels have been shown to be elevated in individuals with excess body weight. Bariatric surgery has become a popular treatment option, leading to stable weight loss and an improvement in obesity-related conditions. The aim of this study was to characterize the factors that promote the induction of metabolic endotoxemia and its associated health consequences, along with the presentation of their changes after bariatric surgery.

Intestinal barrier disorders and metabolic endotoxemia in obesity: Current knowledge

Department of General Endocrine and Transplant Surgery, Faculty of Medicine

Department of Food Commodity Science, Faculty of Health Sciences

Postępy Higieny i Medycyny Doświadczalnej

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The World Health Organization reports that the prevalent problem of excessive weight and obesity currently affects about 1.9 billion people worldwide and is...

Intestinal barrier disorders and metabolic endotoxemia in obesity: Current knowledge

Article Category: Review Study

Publicado en línea: 09 mar 2022

Páginas: 71 - 80

Recibido: 22 abr 2021

Aceptado: 09 sept 2021

DOI: https://doi.org/10.2478/ahem-2022-0008

Palabras clave
gut microbiome, dysbiosis, lipopolysaccharide, endotoxemia, obesity, bariatric surgery, tight junction

© 2022 Marta Potrykus et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Intestinal barrier disorders and metabolic endotoxemia in obesity: Current knowledge

Article Category: Review Study

Publicado en línea: 09 mar 2022

Páginas: 71 - 80

Recibido: 22 abr 2021

Aceptado: 09 sept 2021

DOI: https://doi.org/10.2478/ahem-2022-0008

Palabras clavegut microbiome, dysbiosis, lipopolysaccharide, endotoxemia, obesity, bariatric surgery, tight junction

© 2022 Marta Potrykus et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Palabras clave
gut microbiome, dysbiosis, lipopolysaccharide, endotoxemia, obesity, bariatric surgery, tight junction